中国妇幼健康研究
中國婦幼健康研究
중국부유건강연구
CHINESE JOURNAL OF MATERNAL AND CHILD HEALTH RESEARCH
2013年
4期
550-552
,共3页
薄层液基细胞学检查%绝经后妇女%宫颈癌%筛查
薄層液基細胞學檢查%絕經後婦女%宮頸癌%篩查
박층액기세포학검사%절경후부녀%궁경암%사사
thinprep cytology test (TCT)%postmenopausal women%cervical cancer%screening
目的评价高危型HPV-DNA和薄层液基细胞学检查( TCT)在绝经后妇女宫颈癌筛查中的应用价值。方法随机选择南通市妇幼保健院参加宫颈普查的绝经后妇女346例,同时进行高危型HPV-DNA和TCT检查,发现阳性者即进行病理学活检。结果 HPV-DNA和TCT两种筛查方法的灵敏度比较,差异无统计学意义(P>0.05)。 TCT及HPV-DNA两种筛查方法的阳性预测值分别为19.05%和44.64%,统计学上有显著差异(χ2值分别为12.91AB和12.17AC,P<0.05),与TCT联合HPV筛查的双阳性结果比较,单独HPV筛查的阳性预测值差异无统计学意义(P>0.05)。以病理诊断结果为金标准,ASCUS、LSIL、HSIL、SCC阳性符合率分别为5.56%,27.03%,40.00%,85.71%。结论单一高危型HPV-DNA检测可以作为绝经后妇女宫颈癌筛查的首选方法。
目的評價高危型HPV-DNA和薄層液基細胞學檢查( TCT)在絕經後婦女宮頸癌篩查中的應用價值。方法隨機選擇南通市婦幼保健院參加宮頸普查的絕經後婦女346例,同時進行高危型HPV-DNA和TCT檢查,髮現暘性者即進行病理學活檢。結果 HPV-DNA和TCT兩種篩查方法的靈敏度比較,差異無統計學意義(P>0.05)。 TCT及HPV-DNA兩種篩查方法的暘性預測值分彆為19.05%和44.64%,統計學上有顯著差異(χ2值分彆為12.91AB和12.17AC,P<0.05),與TCT聯閤HPV篩查的雙暘性結果比較,單獨HPV篩查的暘性預測值差異無統計學意義(P>0.05)。以病理診斷結果為金標準,ASCUS、LSIL、HSIL、SCC暘性符閤率分彆為5.56%,27.03%,40.00%,85.71%。結論單一高危型HPV-DNA檢測可以作為絕經後婦女宮頸癌篩查的首選方法。
목적평개고위형HPV-DNA화박층액기세포학검사( TCT)재절경후부녀궁경암사사중적응용개치。방법수궤선택남통시부유보건원삼가궁경보사적절경후부녀346례,동시진행고위형HPV-DNA화TCT검사,발현양성자즉진행병이학활검。결과 HPV-DNA화TCT량충사사방법적령민도비교,차이무통계학의의(P>0.05)。 TCT급HPV-DNA량충사사방법적양성예측치분별위19.05%화44.64%,통계학상유현저차이(χ2치분별위12.91AB화12.17AC,P<0.05),여TCT연합HPV사사적쌍양성결과비교,단독HPV사사적양성예측치차이무통계학의의(P>0.05)。이병리진단결과위금표준,ASCUS、LSIL、HSIL、SCC양성부합솔분별위5.56%,27.03%,40.00%,85.71%。결론단일고위형HPV-DNA검측가이작위절경후부녀궁경암사사적수선방법。
Objective To evaluate the application value of high-risk HPV-DNA and thinprep cytology test ( TCT ) in cervical cancer screening among postmenopausal women .Methods Total 346 postmenopausal women receiving common cervical screening in Nantong Maternity and Child Health Hospital were randomly selected to perform high-risk HPV-DNA and TCT check .The cases with positive results received pathological biopsy .Results The difference in sensitivity of HPV-DNA and TCT was not statistically significant (P>0.05).The positive prediction values of TCT and HPV-DNA were 19.05%and 44.64%, respectively, and the difference was statistically significant (χ2 value was 12.91AB and 12.17AC, respectively, both P<0.05).There was no significant difference between the double positive value of TCT combined with HPV and the positive predictive value of single HPV (P>0.05).Taking pathological diagnosis as gold standard , the positive coincidence rate of ASCUS , LSIL, HSIL and SCC was 5.56%, 27.03%, 40.00%and 85.71%, respectively.Conclusion The single high-risk HPV-DNA test can be used as the preferred method of cervical cancer screening among postmenopausal women .